vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and NWPX Infrastructure, Inc. (NWPX). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $138.3M, roughly 1.2× NWPX Infrastructure, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 19.1%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 3.3%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
ESPR vs NWPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $138.3M |
| Net Profit | — | $10.5M |
| Gross Margin | — | 19.3% |
| Operating Margin | 50.6% | 9.2% |
| Net Margin | — | 7.6% |
| Revenue YoY | 143.7% | 19.1% |
| Net Profit YoY | — | 165.7% |
| EPS (diluted) | $0.32 | $1.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $138.3M | ||
| Q4 25 | $168.4M | $125.6M | ||
| Q3 25 | $87.3M | $151.1M | ||
| Q2 25 | $82.4M | $133.2M | ||
| Q1 25 | $65.0M | $116.1M | ||
| Q4 24 | $69.1M | $119.6M | ||
| Q3 24 | $51.6M | $130.2M | ||
| Q2 24 | $73.8M | $129.5M |
| Q1 26 | — | $10.5M | ||
| Q4 25 | — | $8.9M | ||
| Q3 25 | $-31.3M | $13.5M | ||
| Q2 25 | $-12.7M | $9.1M | ||
| Q1 25 | $-40.5M | $4.0M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | $-29.5M | $10.3M | ||
| Q2 24 | $-61.9M | $8.6M |
| Q1 26 | — | 19.3% | ||
| Q4 25 | — | 21.3% | ||
| Q3 25 | — | 21.3% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 16.7% | ||
| Q4 24 | — | 18.8% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 19.9% |
| Q1 26 | — | 9.2% | ||
| Q4 25 | 50.6% | 10.4% | ||
| Q3 25 | -11.4% | 12.6% | ||
| Q2 25 | 8.6% | 9.9% | ||
| Q1 25 | -34.0% | 4.8% | ||
| Q4 24 | -6.4% | 8.8% | ||
| Q3 24 | -31.0% | 11.9% | ||
| Q2 24 | 3.5% | 10.5% |
| Q1 26 | — | 7.6% | ||
| Q4 25 | — | 7.1% | ||
| Q3 25 | -35.9% | 8.9% | ||
| Q2 25 | -15.4% | 6.8% | ||
| Q1 25 | -62.2% | 3.4% | ||
| Q4 24 | — | 8.4% | ||
| Q3 24 | -57.2% | 7.9% | ||
| Q2 24 | -83.9% | 6.7% |
| Q1 26 | — | $1.08 | ||
| Q4 25 | $0.32 | $0.88 | ||
| Q3 25 | $-0.16 | $1.38 | ||
| Q2 25 | $-0.06 | $0.91 | ||
| Q1 25 | $-0.21 | $0.39 | ||
| Q4 24 | $-0.14 | $1.00 | ||
| Q3 24 | $-0.15 | $1.02 | ||
| Q2 24 | $-0.33 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $14.3M |
| Total DebtLower is stronger | — | $10.7M |
| Stockholders' EquityBook value | $-302.0M | $403.7M |
| Total Assets | $465.9M | $634.1M |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $14.3M | ||
| Q4 25 | $167.9M | $2.3M | ||
| Q3 25 | $92.4M | $2.7M | ||
| Q2 25 | $86.1M | $2.0M | ||
| Q1 25 | $114.6M | $5.3M | ||
| Q4 24 | $144.8M | $5.0M | ||
| Q3 24 | $144.7M | $5.7M | ||
| Q2 24 | $189.3M | $4.5M |
| Q1 26 | — | $10.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $403.7M | ||
| Q4 25 | $-302.0M | $394.8M | ||
| Q3 25 | $-451.4M | $386.4M | ||
| Q2 25 | $-433.5M | $379.5M | ||
| Q1 25 | $-426.2M | $378.5M | ||
| Q4 24 | $-388.7M | $374.0M | ||
| Q3 24 | $-370.2M | $362.4M | ||
| Q2 24 | $-344.2M | $351.2M |
| Q1 26 | — | $634.1M | ||
| Q4 25 | $465.9M | $579.6M | ||
| Q3 25 | $364.0M | $605.2M | ||
| Q2 25 | $347.1M | $592.6M | ||
| Q1 25 | $324.0M | $582.2M | ||
| Q4 24 | $343.8M | $589.7M | ||
| Q3 24 | $314.1M | $617.2M | ||
| Q2 24 | $352.3M | $631.7M |
| Q1 26 | — | 0.03× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $29.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 2.78× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $29.3M | ||
| Q4 25 | $45.2M | $36.0M | ||
| Q3 25 | $-4.3M | $21.0M | ||
| Q2 25 | $-31.4M | $5.4M | ||
| Q1 25 | $-22.6M | $4.8M | ||
| Q4 24 | $-35.0M | $36.1M | ||
| Q3 24 | $-35.3M | $22.7M | ||
| Q2 24 | $-7.2M | $22.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $30.8M | ||
| Q3 25 | — | $13.2M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | — | $31.9M | ||
| Q3 24 | $-35.5M | $16.8M | ||
| Q2 24 | $-7.3M | $16.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 24.5% | ||
| Q3 25 | — | 8.7% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 26.7% | ||
| Q3 24 | -68.7% | 12.9% | ||
| Q2 24 | -9.9% | 12.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 0.0% | 5.2% | ||
| Q2 25 | 0.0% | 2.6% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.0% | 3.5% | ||
| Q3 24 | 0.3% | 4.6% | ||
| Q2 24 | 0.1% | 4.7% |
| Q1 26 | — | 2.78× | ||
| Q4 25 | — | 4.06× | ||
| Q3 25 | — | 1.55× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 2.22× | ||
| Q2 24 | — | 2.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
NWPX
| Water Transmission Systems | $93.5M | 68% |
| Precast Infrastructure and Engineered Systems | $44.8M | 32% |
